BARRETT - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

BARRETT

Description:

High-grade dysplasia Indication of esophagectomy. 22-73% chance unsuspected invasive carcinoma. Esophagogastrectomy. 100% cure rate patient without invasive tumor. – PowerPoint PPT presentation

Number of Views:129
Avg rating:3.0/5.0
Slides: 27
Provided by: vgh4
Category:

less

Transcript and Presenter's Notes

Title: BARRETT


1
BARRETTS ESOPHAGUS
  • GENERAL THORACIC SURGERY
  • CHAPTER 141

2
HISTORY
  • Norman Barrett(1950) congenitally short
    esophagus with an intrathoracic stomach.
  • Allison and Johnstone (1953) and Lortat-Jacob
    (1957)an abnormal columnar epithelium lining the
    distal esophagusBarretts esophagus.
  • Adopt by Barrett himselfacquired, not congenital
    disorder.

3
Definition
  • Normal distal esophagus may display short
    cephalad extention of columnar epithelium above
    the gastroesophageal junction.
  • An endoscopic diagnosis.
  • Circumferential, columnar epithelial lining of
    distal esophagus extending at least 3 cm above
    the gastroesophageal junction.

4
TYPE
  • Gastric fundic type resembling stomach
    epithelium.
  • Junctional epithelium resembling gastric cardia.
  • Intestinal glandular epithelium characterized by
    goblet cell.
  • The intestinalized epithelium is most common and
    importannt histologic type predisposing patient
    to the develop the adenocarcinoma of esophagus.

5
Pathogenesis
  • Gastroesophageal reflux leads to destruction of
    the normal squamous lining of esophagus, and
    allow subsequent cephalad migration of columnar
    gastric lining to re-epithelized the injured
    area.
  • Alkaline reflux also involved, particularly in
    developing complication.
  • Chemotherapy as cyclophosphamide, methotrexate,
    5-FU.
  • Congenital fetal development the columnar
    epithelium is replaced by squamous epithelium,
    island of columnar epithelium persist, usually at
    proximal esophagus, associated with GER.

6
Prevalence
  • 2 of patient undergoing panendoscopy.
  • 44 patient of peptic stricture with Barretts
    esophagus.
  • 27/100000.
  • Autopsy 376/100000.
  • Most barretts esophagus are asymptomatic.

7
Clinical feature
  • Asymptomatic.
  • GER and complication.
  • Heartburn, regurgitation.
  • Dysphagia from stricture or carcinoma.
  • Tobacco and alcohol use.

8
Radiology
  • Difficult to diagnose by radiography.
  • Sliding hiatal hernia with esophagitis.

9
(No Transcript)
10
Endoscopy
  • Essential to confirm diagnosis.
  • Squamous epithelium is more smooth, pale, the
    columnar epithelium is more granular, reddish.
    and often contain signs of reflux injury.
  • Endoscopic biopsy should be performed in all
    suspected cases, to confirm the search for
    dysplasia.
  • Methylene blue associated stain area of
    epithelial dysplasia to guide biopsies.

11
Esophageal manometry and pH testing
  • Diminished lower esophageal sphincter pressure,
    poorer esophageal acid clearance more frequent
    esophageal acid exposure, time of distal
    esophageal pH less than 4 is 15-39.
  • Twice as high as patient with esophagitis without
    Barretts esophagus, 10 fold higher than normal.

12
Biomarkers
  • Alteration in DNA content.
  • p53 mutation.
  • p27 inactived.

13
Complication.
14
Ulceration and stricture
  • More in patient with Barretts esophagus(10-15)
    than in GER.
  • Ulcer penetrate the columnar epithelium, like the
    gastric ulcer, acid-peptic erosion, alkaline
    reflux.
  • s/s bleeding, pain, obstruction(30),
    perforation, irondeficiency anemia, dysphagia,
    perforation into pleural space, lung,
    pericardium.
  • Stricture always at squamocolumnar junction.

15
(No Transcript)
16
Dysplasia
  • Low and high grade.
  • Loss pf nuclear polarity, hyperchromatism,
    nuclear enlargement, stratification,
    pleomorphism, abnormal mitoses.
  • Distinguish high and low grade is difficult.

17
Adenocarcinoma
  • Distinguish adenocarcinomna in Barretts
    esophagus from carcinoma of cardia is difficult.
  • 30-125 times the risk of normal population.
  • 1 case per 100 patient-year, annual risk 1.

18
(No Transcript)
19
Treatment
20
Benign Barretts esophagus
  • Asymptomatic and uncomplication not require
    treatment.
  • Medical treatment of GER infrequently regression
    the Barretts epithelium, or only partial, island
    or underlying columnar epithelium, still at risk
    for dysplasia.
  • Treatment use the same guideline for GER.
  • Antireflux surgery not lessen risk of malignant
    degeneration of Barretts epithelium.

21
Stricture
  • Periodic dilation, weight loss, elevated head of
    bed, dietary modification.
  • Transabdominal Nissen fundoplication coupled with
    intraoperative dilation.
  • Left thoracotomy for complete esophageal
    mobilization to permit lengthening procedure as
    Collis gastroplasty if any display evidence of
    esophageal shortening.

22
Barretts ulcer
  • Most heal with medical therapy H2-blocker, PPI,
    prolong therapy exceeding 8 weeks, response rate
    85.
  • Recurrence common.
  • If ulcer fail to heal after medical treatment 4
    months, the antireflux surgery Collis-Belsey
    repair, Collis-Nissen fundoplication.

23
Low-grade dysplasia
  • Early signal that carcinoma may develop.
  • Most low grade not progress to high grade or
    invasive carcinoma.
  • Medical therapy is recommended even in absence of
    symptoms.
  • More frequent endoscopic surveillance to ensure
    prompt detection.

24
(No Transcript)
25
High-grade dysplasia
  • Indication of esophagectomy.
  • 22-73 chance unsuspected invasive carcinoma.
  • Esophagogastrectomy.
  • 100 cure rate patient without invasive tumor.
  • Thermal laser, photodynamic therapy long term
    efficacy and cost-effectiveness unknown.

26
Adenocarcinoma
  • Esophagogastrectomy.
  • Higher respectability 94-100.
  • Long term survival similar 20 in 5-year.
Write a Comment
User Comments (0)
About PowerShow.com